Literature DB >> 17621274

A high-throughput screening for mammalian cell death effectors identifies the mitochondrial phosphate carrier as a regulator of cytochrome c release.

S Alcalá1, M Klee, J Fernández, A Fleischer, F X Pimentel-Muiños.   

Abstract

Functional annotation of complex genomes requires the development of novel experimental platforms with increased capacity. Here, we describe a high-throughput system designed to identify cDNAs whose overexpression induces morphologically distinct cell death modalities. The methodology incorporates two robotized steps, and relies on coexpression of library clones with GFP to reveal the morphological features presented by the dying cells. By using this system we screened 135 000 cDNA clones and obtained 90 independent molecules. Interestingly, three death categories were identified, namely; apoptotic, vacuolated and autophagic. Among the pro-apoptotic clones, we found four members of the mitochondrial carrier family: the phosphate and adenine nucleotide (type 3) transporters, and the mitochondrial carrier homologs (MTCHs) 1 and 2. Expression of these molecules induced cytochrome c release and caspase-9-dependent death. One of them, the phosphate carrier, was able to interact with members of the permeability transition pore complex ANT1 and VDAC1, and its binding to ANT1 was stabilized in the presence of apoptotic activators. Depletion of this carrier by siRNA delayed cytochrome c mobilization and apoptosis. These results attribute a previously undescribed apoptotic function to the phosphate carrier and, more generally, suggest that a common property of various mitochondrial transporters was exploited during evolution to regulate apoptosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17621274     DOI: 10.1038/sj.onc.1210600

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  34 in total

Review 1.  Cardiolipin, a critical determinant of mitochondrial carrier protein assembly and function.

Authors:  Steven M Claypool
Journal:  Biochim Biophys Acta       Date:  2009-05-05

Review 2.  Regulation and pharmacology of the mitochondrial permeability transition pore.

Authors:  Dmitry B Zorov; Magdalena Juhaszova; Yael Yaniv; H Bradley Nuss; Su Wang; Steven J Sollott
Journal:  Cardiovasc Res       Date:  2009-05-15       Impact factor: 10.787

3.  Mitochondrial apoptosis induced by BH3-only molecules in the exclusive presence of endoplasmic reticular Bak.

Authors:  Martina Klee; Kathrin Pallauf; Sonia Alcalá; Aarne Fleischer; Felipe X Pimentel-Muiños
Journal:  EMBO J       Date:  2009-04-02       Impact factor: 11.598

4.  Genetic deletion of the mitochondrial phosphate carrier desensitizes the mitochondrial permeability transition pore and causes cardiomyopathy.

Authors:  J Q Kwong; J Davis; C P Baines; M A Sargent; J Karch; X Wang; T Huang; J D Molkentin
Journal:  Cell Death Differ       Date:  2014-03-21       Impact factor: 15.828

Review 5.  The still uncertain identity of the channel-forming unit(s) of the mitochondrial permeability transition pore.

Authors:  Christopher P Baines; Manuel Gutiérrez-Aguilar
Journal:  Cell Calcium       Date:  2018-05-16       Impact factor: 6.817

6.  CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms.

Authors:  Sara C Meyer; Matthew D Keller; Sophia Chiu; Priya Koppikar; Olga A Guryanova; Franck Rapaport; Ke Xu; Katia Manova; Dmitry Pankov; Richard J O'Reilly; Maria Kleppe; Anna Sophia McKenney; Alan H Shih; Kaitlyn Shank; Jihae Ahn; Eftymia Papalexi; Barbara Spitzer; Nick Socci; Agnes Viale; Emeline Mandon; Nicolas Ebel; Rita Andraos; Joëlle Rubert; Ernesta Dammassa; Vincent Romanet; Arno Dölemeyer; Michael Zender; Melanie Heinlein; Raajit Rampal; Rona Singer Weinberg; Ronald Hoffman; William R Sellers; Francesco Hofmann; Masato Murakami; Fabienne Baffert; Christoph Gaul; Thomas Radimerski; Ross L Levine
Journal:  Cancer Cell       Date:  2015-07-13       Impact factor: 31.743

7.  miR-141 as a regulator of the mitochondrial phosphate carrier (Slc25a3) in the type 1 diabetic heart.

Authors:  Walter A Baseler; Dharendra Thapa; Rajaganapathi Jagannathan; Erinne R Dabkowski; Tara L Croston; John M Hollander
Journal:  Am J Physiol Cell Physiol       Date:  2012-10-03       Impact factor: 4.249

Review 8.  The molecular composition of the mitochondrial permeability transition pore.

Authors:  Christopher P Baines
Journal:  J Mol Cell Cardiol       Date:  2009-02-20       Impact factor: 5.000

9.  The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition.

Authors:  Anna W C Leung; Pinadda Varanyuwatana; Andrew P Halestrap
Journal:  J Biol Chem       Date:  2008-07-30       Impact factor: 5.157

10.  Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer.

Authors:  Amjad P Khan; Laila M Poisson; Vadiraja B Bhat; Damian Fermin; Rong Zhao; Shanker Kalyana-Sundaram; George Michailidis; Alexey I Nesvizhskii; Gilbert S Omenn; Arul M Chinnaiyan; Arun Sreekumar
Journal:  Mol Cell Proteomics       Date:  2009-11-09       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.